Cancer Gene Therapy: The Next Chapter

Perspectives from the Frontline

 

Tuesday, April 10 at 4pm  – The Harvard Club of New York City

ACGT Fellow and Scientific Advisory Council Member, Carl H. June, MD, will be a keynote speaker along with a panel of leading scientists and biotechnology executives, including:

Usman “Oz” Azam, MD of Tmunity Therapeutics; George Yancopoulos, MD, PhD, President and Chief Scientific Officer of Regeneron; Mitchell Finer, MD, Managing Director of MPM Capital; and André Choulika, PhD, Chairman and Chief Executive Officer, Cellectis.  Rachel Elliott, patient in Dr. Carl June’s CAR T immunotherapy clinical trial, will share her story.

The panel discussion will take place from 4-5:30 pm followed by a cocktail reception from 5:30-7 pm.
This event is open to the public, but space is limited. Tickets are $200 each and sponsorships are available.

For more information, call 203.358.5055 or email Barbara Gallagher.